Hillhouse Capital Management Ltd. 13D and 13G filings for Sagimet Biosciences Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-11-14 4:31 pm Sale |
2024-09-30 | 13G | Sagimet Biosciences Inc. SGMT |
Hillhouse Capital Management Ltd. | 724,800 2.400% |
-724,743![]() (-50.00%) |
Filing |
2024-02-14 4:37 pm Purchase |
2023-12-31 | 13G | Sagimet Biosciences Inc. SGMT |
Hillhouse Capital Management Ltd. | 1,449,543 6.800% |
1,449,543![]() (New Position) |
Filing |